Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 37 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

7%

1 of 14 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (20)
P 4 (1)

Trial Status

Completed14
Recruiting12
Unknown5
Not Yet Recruiting3
Suspended1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT04443023Not ApplicableCompletedPrimary

Comparison of Eligible TAVI-valves - Cohort B

NCT07506382RecruitingPrimary

Comparative Observational Study of Supra-annular Versus Intra-annular Self-expanding Aortic Valves in Routine Clinical Practice

NCT06197503Not ApplicableRecruitingPrimary

Randomized Study of Physiological vs Right Ventricular Pacing in Patients With Normal Ventricular Function Post TAVI

NCT05804903Not ApplicableSuspendedPrimary

Investigation of the NVT ALLEGRA Plus THV System in Patients With Severe Aortic Stenosis or Failed Surgical Aortic Bioprosthesis

NCT06602609Not ApplicableRecruiting

Remote Cardiovascular Monitoring in Post-TAVI Patients

NCT05478161Not ApplicableCompletedPrimary

Investigation of the ALLEGRA THV System With a New Delivery System in Patients With Aortic Stenosis or Failed Surgical Bioprosthesis

NCT07309029Recruiting

Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR

NCT06773780Not ApplicableRecruiting

Transcatheter Aortic Valve Implantation: Comparison of the Effects of Ultrasound-Guided Pericapsular Nerve Group Block and Fascia Iliaca Block on Postoperative Analgesia Management

NCT03613246Active Not RecruitingPrimary

NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population

NCT07217691Not ApplicableNot Yet Recruiting

Optimization of Commissural Alignment During Transcatheter Aortic Valve Implantation With Evolut FX+

NCT05217888Completed

The Sentinel Registry

NCT06896227Not ApplicableRecruiting

TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics

NCT06834828Completed

Prevalence of Cusp Asymmetry, Coronary Ostial Eccentricity in Patients Undergoing Trans Catheter Aortic Valve Implantation and Their Impact on Coronary Ostia Overlap Risk Assessment

NCT01777828RecruitingPrimary

Registry of Aortic Valve Bioprostheses Established by Catheter

NCT06189976Not ApplicableRecruiting

Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation

NCT05133843Not ApplicableRecruiting

Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis

NCT05491070Not ApplicableCompleted

Comparison of Different Vascular Closure Device in TAVI

NCT06481137Not ApplicableRecruiting

Reversibility of Cardiac Conduction Disturbances Following TAVI

NCT06212050Enrolling By Invitation

Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis

NCT02976792CompletedPrimary

Effectiveness of the NephroCheck™ After TAVI

Scroll to load more

Research Network

Activity Timeline